US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic macular oedema (DMO) treatment. The open-label, dose-escalation trial will ...

Ferric carboxymaltose, an IV iron replacement therapy, did not reduce the time to first HF hospitalization or CV death for patients with HF and iron deficiency, according to results of a late-breaking ...

Canola and a team of researchers analyzed ferritin, which stores iron and increases during acute inflammation, and ...

Transferrin is a protein in the blood that transports iron throughout your body. Examining how much iron is in the transferrin proteins can tell your doctor if you have too much or too little iron ...